Systematic Financial Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-14,235
Closed -$284K 647
2018
Q4
$284K Sell
14,235
-6,535
-31% -$151K 0.01% 596
2018
Q3
$590K Buy
20,770
+2,000
+11% +$47.7K 0.01% 590
2018
Q2
$395K Hold
18,770
0.01% 599
2018
Q1
$267K Hold
18,770
0.01% 616
2017
Q4
$231K Sell
18,770
-7,345
-28% -$104K ﹤0.01% 620
2017
Q3
$465K Sell
26,115
-161,675
-86% -$3.33M 0.01% 587
2017
Q2
$4.76M Sell
187,790
-815
-0.4% -$19.6K 0.09% 255
2017
Q1
$4.21M Sell
188,605
-1,525
-0.8% -$29.3K 0.07% 267
2016
Q4
$2.81M Buy
190,130
+19,210
+11% +$378K 0.04% 324
2016
Q3
$4.21M Sell
170,920
-10,355
-6% -$242K 0.06% 284
2016
Q2
$3.48M Buy
+181,275
New +$2.49M 0.05% 289

Other funds holding EVH

Systematic Financial Management's EVH Position: Q1 2019 in Review

Systematic Financial Management sold out of Evolent Health (EVH) in Q1 2019, closing a stake of 14,235 shares — an estimated $284K sold.

Systematic Financial Management first reported a position in EVH in Q2 2016 and held it in 11 quarters. The position peaked at $4.76M in Q2 2017. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2019.

  • Systematic Financial Management reported no remaining Evolent Health position as of Q1 2019 after selling out during the quarter.
  • Systematic Financial Management sold 14,235 Evolent Health shares in Q1 2019, an estimated $284K.
  • Systematic Financial Management first reported a position in Evolent Health in Q2 2016 and held it in 11 quarters.
  • Systematic Financial Management's Evolent Health position peaked at $4.76M in Q2 2017.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2019.

Based on Systematic Financial Management's 13F filing for Q1 2019, filed 3 May 2019.